Søren Møller

Professor

Hvidovre Hospital

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Søren Møller is a faculty member at Hvidovre Hospital, Denmark. His research primarily focuses on cardiovascular implications related to metabolic dysfunction-associated liver disease, cirrhosis, and inflammatory bowel disease. Recent articles authored by Professor Møller include studies on the hemodynamic effects of terlipressin, incidence of osteoporosis in inflammatory bowel disease, and markers of inflammation predicting survival in cirrhosis patients.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Collaborators (5)

Guruprasad P. Aithal

UNITED KINGDOM

View details

Henry Webel

Københavns Universitet

DENMARK

View details

Nina Kimer

DENMARK

View details

Flemming Bendtsen

Faculty of Health and Medical Sciences, University of Copenhagen

DENMARK

View details

Signe Wiese

Zealand University Hospital Køge

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Søren Møller

Research Interests

Contact this professor

About

Articles (14)

Cardiovascular implications of MASLD: overview of the evidence

Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging

The heterogeneity of cirrhosis - systemically assessed endotypes described by fibrosis, apoptosis, and immunoregulatory-related biomarkers

Incidence of Osteoporosis and Osteopenia in Newly Diagnosed Inflammatory Bowel Disease: A Population-Based Cohort Study

Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects

Cardiac dysfunction in patients with cirrhosis and acute decompensation

Low sphingolipid levels predict poor survival in patients with alcohol-related liver disease

Quantitative Assessment of Body Composition in Cirrhosis

Effect of beta‐blockers on multiple haemodynamics in cirrhosis: A cross‐over study by MR‐imaging and hepatic vein catheterization

How non-alcoholic fatty liver disease and cirrhosis affect the heart

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Determination of hepatic clearance by derivations of the indocyanine green retention test in cirrhosis

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation

Pituitary adenylate cyclase‐activating peptide: Potential roles in the pathophysiology and complications of cirrhosis

Collaborators (5)

Guruprasad P. Aithal

Henry Webel

Nina Kimer

Flemming Bendtsen

Signe Wiese

Make your next move.